🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the bioequivalence of the two treatments...
Status
Unknown
Location
Samsung Medical Center
Start Date
2014-06
Trial ID
NCT02173912
Treatments Being Tested
This single dose study was designed in accordance with EMA (the European Me...
Status
Completed
Location
Altasciences Company Inc.
Start Date
2019-07-11
Trial ID
NCT04012307
Treatments Being Tested
The purpose of this study is to evaluate the non-inferiority clinical effic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02521233
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
Changes to gastric pH, gastric emptying time, gastrointestinal transit-time...
Status
Recruiting
Location
St. Olavs University Hospital
Start Date
2016-11-02
Trial ID
NCT03460327
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic interaction of...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00905333
Treatments Being Tested
This study will investigate the relative bioavailability of two candidate t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-02
Trial ID
NCT02254447
Treatments Being Tested
The COVID-RASi study is an international randomized clinical trial that wil...
Status
Completed
Location
Centro de Pesquisa Clinicas Dr Marco Mota
Start Date
2021-01-27
Trial ID
NCT04591210
Treatments Being Tested
This will be an open-label, randomized, single dose, two-way crossover stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-12-11
Trial ID
NCT02006589